Atlas Trials

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Clinical trial NCT06334133 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06334133
Sponsor
vTv Therapeutics
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2024-06-14
Primary completion
2027-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.